Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3344272
Max Phase: Preclinical
Molecular Formula: C36H54F3N7O8S
Molecular Weight: 687.91
Molecule Type: Small molecule
Associated Items:
ID: ALA3344272
Max Phase: Preclinical
Molecular Formula: C36H54F3N7O8S
Molecular Weight: 687.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NS(=O)(=O)Cc1ccccc1)C(C)C)[C@@H](O)CC(=O)NCCc1ccccc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H53N7O6S.C2HF3O2/c1-23(2)20-28(29(42)21-30(43)37-19-17-25-12-7-5-8-13-25)39-33(45)31(24(3)4)40-32(44)27(16-11-18-38-34(35)36)41-48(46,47)22-26-14-9-6-10-15-26;3-2(4,5)1(6)7/h5-10,12-15,23-24,27-29,31,41-42H,11,16-22H2,1-4H3,(H,37,43)(H,39,45)(H,40,44)(H4,35,36,38);(H,6,7)/t27-,28-,29-,31-;/m0./s1
Standard InChI Key: IMOBLHMHUQICCG-XCUOUWGKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 687.91 | Molecular Weight (Monoisotopic): 687.3778 | AlogP: 1.52 | #Rotatable Bonds: 21 |
Polar Surface Area: 215.60 | Molecular Species: BASE | HBA: 7 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.38 | CX Basic pKa: 11.71 | CX LogP: 1.32 | CX LogD: -0.37 |
Aromatic Rings: 2 | Heavy Atoms: 48 | QED Weighted: 0.05 | Np Likeness Score: -0.04 |
1. Sleebs BE, Gazdik M, O'Neill MT, Rajasekaran P, Lopaticki S, Lackovic K, Lowes K, Smith BJ, Cowman AF, Boddey JA.. (2014) Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax., 57 (18): [PMID:25167370] [10.1021/jm500797g] |
2. Nguyen W, Hodder AN, de Lezongard RB, Czabotar PE, Jarman KE, O'Neill MT, Thompson JK, Jousset Sabroux H, Cowman AF, Boddey JA, Sleebs BE.. (2018) Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics., 154 [PMID:29800827] [10.1016/j.ejmech.2018.05.022] |
Source(1):